Please click on SAMPLE PAGES to view contents and example pages of the report
A new report by PatientView finds that …
“Having a fair pricing policy” stands out as an important strategy that 600 respondent patient groups recommend pharmaceutical companies should adopt to enhance corporate reputation. The majority of the respondent patient groups believe that few companies have, as yet, been able to attain such a goal. Analysis included for Canada, France, Germany, Italy, Spain, UK, and the USA.
Four senior patient advocates discuss market access in times of austerity
View original post 234 more words